Supplementary Figure S1 from Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial
crossref(2024)
Abstract
Figure S1. Effect of Nicotinamide on the expressions of RUNX1 and RUNX3 in urethaneinduced mouse lung cancers and human lung cancer cell lines
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined